Stock Market & Financial Investment News

News Breaks September 5, 2012 08:55 EDT JNJ FDA grants priority review to Janssen's bedaquiline Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application for bedaquiline to treat pulmonary, multi-drug resistant tuberculosis in adults as part of combination therapy. The FDA grants priority review to medicines that may offer major advances in care or provide a treatment option where no adequate therapy exists. Under the Prescription Drug User Fee Act, the FDA will aim to complete its review within six months of the NDA submission. The NDA was submitted June 29. News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 10:08 EDT JNJ On The Fly: Analyst Initiation Summary Subscribe for More Information 08:14 EDT JNJ Carter's Global Consumer Products Analysts discuss the possibility of China retiring the one-child policy within the year and potential implications for consumer products on an Analyst/Industry conference call. Relevant covered companies JNJ, PG, PFE, ABT, KMB, MJN and CRI which may be impacted and discussed on the Analyst/Industry conference call to be held on May 23 at 10 am. 07:31 EDT JNJ Janssen expects to have more than 25 brand line extensions by 2017 Subscribe for More Information 06:29 EDT JNJ Johnson & Johnson coverage assumed with an Underperform at Credit Suisse Subscribe for More Information May 22, 2013 16:00 EDT JNJ Options Update; May 22, 2013 Subscribe for More Information May 21, 2013 07:24 EDT JNJ Global Health Care to host a conference Subscribe for More Information May 17, 2013 06:19 EDT JNJ J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports Subscribe for More Information May 15, 2013 16:51 EDT JNJ FDA approves Simponi to treat ulcerative colitis Subscribe for More Information May 10, 2013 11:48 EDT JNJ Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 06:16 EDT JNJ Obesity surgery booming in India, Bloomberg reports Subscribe for More Information May 9, 2013 17:09 EDT JNJ Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link 09:51 EDT JNJ J&J unit says first patient enrolled in reMARQable study Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.